PDS BIOTECHNOLOGIESLOGY CORP
PDS BIOTECHNOLOGIESLOGY CORP
Action · US70465T1079 · PDSB · A2PF3F (XNCM)
Aperçu Indicateurs financiers
1,82 USD
6,14 % 0,10 USD
NASDAQ CAPITAL MARKET (XNAS) · Cours et graphiques actuels sur MoneyPeak
12.06.2025 17:19

Cours actuels de PDS BIOTECHNOLOGIESLOGY CORP

BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
PDSB
USD
12.06.2025 17:19
1,82 USD
1,76 USD
+3,42 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
6,14 % 16,98 % 52,37 % 50,00 % -12,53 % -34,24 % 52,52 %

Profil de l'entreprise pour PDS BIOTECHNOLOGIESLOGY CORP Action

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.

Données de l'entreprise

Nom PDS BIOTECHNOLOGIESLOGY CORP
Société PDS Biotechnology Corporation
Symbole PDSB
Site web https://www.pdsbiotech.com
Marché d'origine XNCM NASDAQ CAPITAL MARKET
WKN A2PF3F
ISIN US70465T1079
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Dr. Frank K. Bedu-Addo Ph.D.
Capitalisation boursière 50 Mio
Pays États-Unis d'Amérique
Devise USD
Employés 0,0 T
Adresse 25B Vreeland Road, 07932 Florham Park
Date d'introduction en bourse 2015-09-30

Aktien-Splits

Datum Split
18.03.2019 1:20

Kennungs-Wechsel

Datum Von Zu
18.03.2019 EDGE PDSB

Ticker Symbole

Name Symbol
Frankfurt EU6.F
NASDAQ PDSB

Weitere Aktien

Investoren die PDS BIOTECHNOLOGIESLOGY CORP die halten, haben auch folgende Aktien im Depot:
APPLE INC
APPLE INC Aktie
CERES POWER S
CERES POWER S Aktie
CNP ASSURANC 19/29
CNP ASSURANC 19/29 Anleihe
DAIMLER TRUCK HOLDING AG
DAIMLER TRUCK HOLDING AG Aktie
DEUTSCHE TELEKOM AG
DEUTSCHE TELEKOM AG Aktie
FREEMAN GOLD CORP
FREEMAN GOLD CORP Aktie
ITM POWER PLC
ITM POWER PLC Aktie
JUST EAT TAKEAWAY.CO NV
JUST EAT TAKEAWAY.CO NV Aktie
KEURIG DR P. 25/28
KEURIG DR P. 25/28 Anleihe
LILIUM NV CL.A     EO1
LILIUM NV CL.A EO1 Aktie
MERCEDES BENZ GROUP AG
MERCEDES BENZ GROUP AG Aktie
META PLATFORMS INC
META PLATFORMS INC Aktie
NETFLIX INC
NETFLIX INC Aktie
TESLA INC
TESLA INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025